In summary, our experiments revealed that by regulating the composition of GM, such as Akkermansia, SYD might interact with the IL‐17/TNF/NF‐κB signaling axis, enhancing intestinal immunity, metabolic pathways, and inflammatory responses to influence the development and progression of CRC. Here, IL17A is linked to colorectal carcinoma.